Better Treatment for Hepatitis C
A new combination drug therapy may be able to help people with even some of the most difficult-to-treat forms of hepatitis C manage their disease and prevent complications.
Read the Article
|
Hep C Drug Combo for Difficult Cases
Patients with liver damage from the hepatitis C virus who fail treatment may be able to get a new lease on life, thanks to an aggressive treatment that uses an old standby drug in a new way, say German researchers.
Read the Article
|
New Gene Tool Stops Liver Damage
Last year it was the scientific breakthrough of the year. Tomorrow it may be called a new treatment for hepatitis and other liver woes. It's called RNA interference or RNAi. Discovered only last year, it's an amazing tool. If you know the DNA code for any gene, you can use RNAi to switch that gene off. At least it works that way in the test tube.
Read the Article
|
New Hepatitis B Drug Better Than Others
A new drug appears to be giving patients with chronic hepatitis B something they have not had before -- effective suppression of their virus without the acquired resistance and hard-to-live-with side effects that have plagued current treatments.
Read the Article
|
Tattoo and Piercing Still Risky
Tattoo art and body piercing are popular forms of self-expression. But body art carries a downright dangerous risk of serious infection, including hepatitis C and HIV. Kids need to think twice about it. But if they're sold on the idea, at least make sure the shop is using clean needles and instruments.
Read the Article
|
Hepatitis C Achilles Heel Found
The central mystery of hepatitis C now is solved. A new finding promises more effective, shorter, and easier hepatitis C treatments. What Michael Gale Jr., PhD, and colleagues discovered is how hepatitis C virus establishes lifelong infection. They found that the virus makes a key that lets it turn off a cell's anti-virus machinery. And they found that a type of drug -- already in development by several companies -- robs the virus of this key. Without it, the anti-viral machinery comes to life. It churns out a chemical called interferon that rids the cell of the hepatitis C virus.
Read the Article
|
More Effective Hepatitis B Treatment
A new form of an old hepatitis drug appears to be a more effective hepatitis B treatment. Twice as many patients taking a longer-acting version of the drug interferon -- called pegylated interferon -- had effective results as patients on standard interferon.
Read the Article
|
Study: Twice Weekly Dose Better for Hep C
New research suggests the best treatment for hepatitis C virus may be even more effective if given twice weekly rather than once a week, but experts contacted by WebMD say the study is far from convincing.
Read the Article
|
Experimental Hepatitis C Drug 'Promising'
Roughly half of all patients infected with hepatitis C virus can be cured. And now, an experimental drug is showing promise for the other half who don't respond to first-line hepatitis C drugs.
Read the Article
|
Hepatitis E Vaccine Shows Promise
An experimental hepatitis E vaccine shows promise but needs further study, experts report in The New England Journal of Medicine. Hepatitis E is a liver disease caused by the hepatitis E virus, which spreads through contaminated food or water.
Read the Article
|
Hepatitis C May Up Some Lymphoma
Hepatitis C may make non-Hodgkin's lymphoma more likely, researchers report in The Journal of the American Medical Association. That may mean that people with hepatitis C should be screened for non-Hodgkin's lymphoma, note the researchers, who included Eric Engels, MD, MPH, of the National Cancer Institute.
Read the Article
|
Blood Marker Might Help Spot Early Liver Cancer
Chinese researchers have identified a liver cancer marker in blood that may help identify patients with early-stage liver cancer and predict how well they'll do after treatment. They found an altered version of RASSF1A -- a tumor suppressing gene -- in the blood of patients with hepatocellular carcinoma (HCC) and in 58 percent of patients infected with hepatitis B virus (HBV), which increases the risk of liver cancer.
Read the Article
|
Cirrhosis Can Impact Heart Surgery Success
For patients with cirrhosis, the severity of the disease will predict how well they do after heart surgery, a new study finds. While milder cases of the liver ailment will have less of an impact on heart surgery outcomes, patients with severe cirrhosis may require alternative approaches to managing their heart disease, according to research published in the July issue of Liver Transplantation.
Read the Article
|
Key Factors Spur Hepatitis C Treatment Success
Successful treatment of hepatitis C may depend on the type of interferon given to patients and the viral strain, researchers say. The study also confirmed that other factors, such as Caucasian race, the absence of cirrhosis and elevated levels of the liver enzyme ALT, all predict successful treatment.
Read the Article
|
|
Page: 1 2 3 4
Members currently browsing this category:
|
